Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 2001 to 2050 of 6456 in total
Value Type: Ranked
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1001\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dopachrome tautomerase precursor (ec 5.3.3.12) (dt) (dct) (dopachrome delta-isomerase) (tyrosinase-related protein 2) (trp-2) (trp2). [source:swissprot;acc:p40126]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.409\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.871\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sprouty homolog 3 (spry-3). [source:swissprot;acc:o43610]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.167\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.922\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03325\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1002\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
5,6-dihydroxyindole-2-carboxylic acid oxidase precursor (ec 1.14.18.-) (dhica oxidase) (tyrosinase-related protein 1) (trp-1) (trp1) (trp) (catalase b) (glycoprotein-75) (melanoma antigen gp75). [source:swissprot;acc:p17643]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.278\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.409\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.869\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sprouty homolog 1 (spry-1) (fragment). [source:swissprot;acc:o43609]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.167\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.922\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03325\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1003\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
pinin, desmosome associated protein; pinin. [source:refseq;acc:nm\_002687]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.071\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.205\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.866\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sprouty homolog 2 (spry-2). [source:swissprot;acc:o43597]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.167\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.922\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03325\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1004\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
sh2 domain binding protein 1; tpr-containing, sh2-binding phosphoprotein. [source:refseq;acc:nm\_014633]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
238.725\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
231.059\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03318\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
skeletal muscle lim-protein 2 (slim 2) (four and a half lim domains protein 3) (fhl-3). [source:swissprot;acc:q13643]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
269.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
276.454\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.864\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1005\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dynein intermediate chain 1, cytosolic (dh ic-1) (cytoplasmic dynein intermediate chain 1). [source:swissprot;acc:o14576]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.448\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.232\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03307\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
dyskerin (nucleolar protein nap57) (cbf5 homolog). [source:swissprot;acc:o60832]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
231.007\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
237.864\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.857\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1006\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage and polyadenylation specificity factor, 73 kda subunit (cpsf 73 kda subunit). [source:swissprot;acc:q9ukf6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
116.524\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
120.375\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03305\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
retinoblastoma-like protein 2 (130 kda retinoblastoma-associated protein) (prb2) (p130) (rbr-2). [source:swissprot;acc:q08999]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.026\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.189\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.837\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1007\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ral guanine nucleotide dissociation stimulator (ralgef) (ralgds). [source:swissprot;acc:q12967]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
162.055\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
156.884\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03296\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
retinoblastoma-like protein 1 (107 kda retinoblastoma-associated protein) (prb1) (p107). [source:swissprot;acc:p28749]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.021\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.185\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.836\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1008\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna damage binding protein 1 (damage-specific dna binding protein 1) (ddb p127 subunit) (ddba) (uv-damaged dna-binding protein 1) (uv-ddb 1) (xeroderma pigmentosum group e complementing protein) (xpce) (x- associated protein 1) (xap-1). [source:swissprot;acc:q16531]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
222.364\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.535\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.829\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
wd-repeat protein bing4. [source:swissprot;acc:o15213]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
243.227\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.475\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03292\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1009\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dihydropyrimidine dehydrogenase [nadp+] precursor (ec 1.3.1.2) (dpd) (dhpdhase) (dihydrouracil dehydrogenase) (dihydrothymine dehydrogenase). [source:swissprot;acc:q12882]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
229.116\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.823\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03288\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
propionyl-coa carboxylase beta chain, mitochondrial precursor (ec 6.4.1.3) (pccase beta subunit) (propanoyl-coa:carbon dioxide ligase beta subunit). [source:swissprot;acc:p05166]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.364\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.535\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.829\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1010\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ataxin 2 related protein isoform a; ataxin-2 domain protein. [source:refseq;acc:nm\_007245]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
228.105\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.293\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.812\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal carnitine octanoyltransferase (ec 2.3.1.-) (cot). [source:swissprot;acc:q9ukg9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.523\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.648\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03264\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1011\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ataxin 2; olivopontocerebellar ataxia 2, autosomal dominant. [source:refseq;acc:nm\_002973]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.105\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.293\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.812\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
retinoblastoma-like protein 2 (130 kda retinoblastoma-associated protein) (prb2) (p130) (rbr-2). [source:swissprot;acc:q08999]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.026\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.189\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03253\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1012\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin alpha-4 subunit (karyopherin alpha-4 subunit) (qip1 protein). [source:swissprot;acc:o00629]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.369\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.561\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.808\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
retinoblastoma-like protein 1 (107 kda retinoblastoma-associated protein) (prb1) (p107). [source:swissprot;acc:p28749]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.021\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.185\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03252\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1013\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein bap28. [source:swissprot;acc:q9h583]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
244.312\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
236.647\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03239\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
target of egr1, member 1 (nuclear); target of egr1, member 1. [source:refseq;acc:nm\_025077]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.365\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.558\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.807\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1014\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
apoptosis antagonizing transcription factor. [source:refseq;acc:nm\_012138]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
243.045\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.422\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03238\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
importin alpha-3 subunit (karyopherin alpha-3 subunit) (srp1-gamma). [source:swissprot;acc:o00505]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.361\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.554\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.807\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1015\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
bai1-associated protein 1; ww domain-containing protein 3; atrophin-1 interacting protein 3. [source:refseq;acc:nm\_004742]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
228.906\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03236\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
exocyst complex component sec6. [source:swissprot;acc:o60645]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.186\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
200.398\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.788\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1016\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin alpha-4 subunit (karyopherin alpha-4 subunit) (qip1 protein). [source:swissprot;acc:o00629]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.369\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.561\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03233\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosinase precursor (ec 1.14.18.1) (monophenol monooxygenase) (tumor rejection antigen ab) (sk29-ab) (lb24-ab). [source:swissprot;acc:p14679]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.183\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.406\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.777\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1017\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
succinyl-coa ligase [gdp-forming] alpha-chain, mitochondrial precursor (ec 6.2.1.4) (succinyl-coa synthetase, alpha chain) (scs-alpha). [source:swissprot;acc:p53597]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
211.908\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.627\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.719\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
target of egr1, member 1 (nuclear); target of egr1, member 1. [source:refseq;acc:nm\_025077]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.365\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.558\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03233\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1018\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin alpha-3 subunit (karyopherin alpha-3 subunit) (srp1-gamma). [source:swissprot;acc:o00505]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
217.361\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.554\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
succinyl-coa ligase [adp-forming] beta-chain, mitochondrial precursor (ec 6.2.1.5) (succinyl-coa synthetase, betaa chain) (scs-betaa) (atp- specific succinyl-coa synthetase beta subunit). [source:swissprot;acc:q9p2r7]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.908\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.627\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.719\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1019\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l21. [source:swissprot;acc:p46778]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
223.958\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.695\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosinase-related gene segment, exon 5 (fragment). [source:sptrembl;acc:q15677]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.302\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
214.409\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03215\vspace{3pt}}\\\cline{1-2}\cline{4-4}\cline{6-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1020\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dopachrome tautomerase precursor (ec 5.3.3.12) (dt) (dct) (dopachrome delta-isomerase) (tyrosinase-related protein 2) (trp-2) (trp2). [source:swissprot;acc:p40126]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
221.28\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
1.03205\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
similar to ribosomal protein, large, p0. [source:sptrembl;acc:q96fq9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.218\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
232.88\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.662\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1021\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
5,6-dihydroxyindole-2-carboxylic acid oxidase precursor (ec 1.14.18.-) (dhica oxidase) (tyrosinase-related protein 1) (trp-1) (trp1) (trp) (catalase b) (glycoprotein-75) (melanoma antigen gp75). [source:swissprot;acc:p17643]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.278\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.409\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03204\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
block 23. [source:sptrembl;acc:q8nhw5]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.205\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
232.858\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.653\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1022\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s acidic ribosomal protein p0 (l10e). [source:swissprot;acc:p05388]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
226.203\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
232.855\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.652\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cystathionine beta-synthase (ec 4.2.1.22) (serine sulfhydrase) (beta-thionase). [source:swissprot;acc:p35520]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
205.632\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
199.266\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03195\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1023\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
gcn5-like protein 1 (rt14 protein). [source:swissprot;acc:p78537]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.027\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
195.386\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.641\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transforming protein rhoc (h9). [source:swissprot;acc:p08134]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
205.632\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
199.266\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03195\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1024\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dolichol-phosphate mannosyltransferase (ec 2.4.1.83) (dolichol- phosphate mannose synthase) (dolichyl-phosphate beta-d- mannosyltransferase) (mannose-p-dolichol synthase) (mpd synthase) (dpm synthase). [source:swissprot;acc:o60762]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.381\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
196.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.621\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
thiosulfate sulfurtransferase (ec 2.8.1.1) (rhodanese). [source:swissprot;acc:q16762]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
205.632\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
199.266\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03195\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1025\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
3-mercaptopyruvate sulfurtransferase (ec 2.8.1.2) (mst). [source:swissprot;acc:p25325]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s30. [source:swissprot;acc:q05472]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.875\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6.565\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/